It was revealed that the combination indexes for the indicated concentrations of BET inhibitors and cytarabine were less than 1 in both A375 and SK‐MEL‐28 melanoma cells (Figure 6K,L and Figure S9C,D), suggesting the beneficial synergistic effect of BET inhibitors and cytarabine in the treatment of melanoma. This evidence concerns the gene DNER and melanoma.